3/1/2021 2:32:40 PM
Aikido Pharma is developing a drug portfolio to
Aikido Pharma is developing a drug portfolio to treat acute lymphoblastic leukemia (ALL). cancer along with three other main cancer types. Our drug portfolio combined with AIkido Pharma Inc. ’s platform offers a robust drug pipeline focused on the development and commercialization of drugs to treat unmet medical needs in oncology. Get in touch with Aikido Pharma today by calling 212-745-1373.
-
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics
2/28/2021 4:30:00 AM
2/28/2021 2:30:00 AM
2/28/2021 1:30:00 AM
2/28/2021 12:30:00 AM
2/27/2021 9:30:00 PM
2/27/2021 4:30:00 AM
2/27/2021 2:30:00 AM
2/27/2021 1:30:00 AM
2/27/2021 12:30:00 AM
2/26/2021 10:30:00 PM
2/26/2021 9:30:00 PM
2/26/2021 4:30:00 AM
2/26/2021 1:30:00 AM
2/26/2021 1:00:00 AM
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
